Organ-specific mitochondrial heterogeneity: An under-recognized variable in preclinical drug toxicity screening

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Mitochondria display significant organ-specific heterogeneity due to diverse physiological and metabolic demands.
• Variations in bioenergetics, oxidative stress, calcium handling, and metabolism influence mitochondrial drug responses and organ toxicity.
• Current preclinical drug screening often uses generalized models that may miss organ-specific mitochondrial vulnerabilities.

Purpose of the Study:

• To highlight the importance of organ-specific mitochondrial physiology in drug safety.
• To propose integrating organ-adapted mitochondrial insights into preclinical drug toxicity evaluation.
• To enhance the predictive accuracy and translational relevance of toxicology studies.

Main Methods:

• Reviewing existing literature on mitochondrial heterogeneity and drug toxicity.
• Identifying key mitochondrial functions that differ across organs.
• Exploring novel approaches for assessing organ-specific mitochondrial responses.

Main Results:

• Organ-specific mitochondrial differences significantly impact drug metabolism and toxicity.
• Generalized preclinical models may fail to identify organ-selective drug liabilities.
• Integrating organ-adapted models is crucial for accurate toxicity prediction.

Conclusions:

• Understanding organ-specific mitochondrial physiology is essential for robust drug safety assessment.
• Tissue-relevant cellular models and functional assays are needed.
• Adopting these approaches will improve predictive toxicology and translational relevance.